Trial intelligence / Profile preview

Oral acetaminophen premedication for propofol injection pain

IRCT20210511051268N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of acetaminophen in None (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Extent of local pain after intravenous injection of propofol. Started Jun 2021; status: completed.

02

Drugs

acetaminophen

Beyond the preview

Go deeper on IRCT20210511051268N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210511051268N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call